Skip to main content

Coleen A McNamara

NIH Rank #3357
  • R01 Holder
  • Early Career
  • Mentor

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1876677Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology
  • Surgery
  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$3M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,357
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Coleen A McNamara. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Coleen A McNamara as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI172112-04R01
    IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
    $1M
    award amount
  • 5R01HL172888-02R01
    Targeted approach to the mitigation of abdominal aortic aneurysm
    $709.4K
    award amount
  • 3R01AI172112-04S1R01
    IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
    $522.7K
    award amount
  • 5T32AI007496-30T32
    Interdisciplinary Training Program in Immunology
    $465.4K
    award amount
  • 1R01HL176892-01R01
    G6PD Deficiency and Atherosclerosis
    $323K
    award amount

Award organization

Organizations that administered FY2025 awards listing Coleen A McNamara as a PI.

FY2025 award administered by University of Virginia (VA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4663
  6. 2024
    Entered Top 25% Nationally
    Ranked #4663
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2026
    Entered Top 10% Nationally
    Ranked #1980